A One Health scoping review of genomic and machine learning approaches for predicting antimicrobial resistance in low- and middle-income countries

Antimicrobial resistance (AMR) is a major global health threat, disproportionately affecting low- and middle-income countries (LMICs), where limited laboratory infrastructure constrains phenotypic antimicrobial susceptibility testing. Whole-genome sequencing (WGS)-enabled machine learning (ML) and artificial intelligence (AI) offer rapid approaches for AMR prediction, but their applicability across heterogeneous populations and One Health reservoirs remains uncertain. To map genomic ML/AI approaches for bacterial AMR prediction, focusing on genomic features, model architectures, validation, performance, and LMIC and One Health applicability. A scoping review of 27 studies published between 2020 and 2026 was conducted, including 22 with LMIC-relevant datasets. Evidence was narratively synthesized according to genomic features, modelling strategies, validation approaches, geographic coverage, and ecological context. Studies were categorized using predefined LMIC relevance and One Health criteria. Most studies used WGS-derived features, particularly k-mers and resistance-gene profiles. Tree-based ensembles and regularized regression models predominated, while neural networks were less frequently applied but generally reported high performance. Reported performance ranged from 78%–98% (accuracy or AUC; not directly comparable). External validation using independent LMIC-derived or cross-regional datasets was reported in approximately 30% of studies, whereas cross-country LMIC validation was limited. Six of 22 LMIC-relevant studies (27.3%) incorporated multi-reservoir One Health datasets. Performance varied with dataset composition, genomic feature representation, and model architecture. Explainable AI remained limited. Genomic ML/AI shows strong potential for AMR prediction but remains constrained by limited LMIC representation, external validation, and One Health integration. Expanding geographically diverse WGS datasets, strengthening independent cross-context and cross-country validation, harmonizing evaluation frameworks, and integrating explainable AI are priorities for equitable LMIC deployment.

Authors

Institutions

Publication Details

Journal
Discover Public Health
Published
2026-10-18
DOI
https://doi.org/10.1186/s12982-026-02998-5
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A One Health scoping review of genomic and machine learning approaches for predicting antimicrobial resistance in low- and middle-income countries

Mecky Isaac Matee, Salim S. Masoud, Zuhura Idd Kimera, Upendo Ozeniel Kibwana et al.
Discover Public Health
Antibiotic Resistance in Bacteria
article

A One Health scoping review of genomic and machine learning approaches for predicting antimicrobial resistance in low- and middle-income countries

Mecky Isaac Matee, Salim S. Masoud, Zuhura Idd Kimera, Upendo Ozeniel Kibwana, Erasto Vitus Mbugi, Doreen Kamori, Majigo Mtebe
article en

Abstract

Antimicrobial resistance (AMR) is a major global health threat, disproportionately affecting low- and middle-income countries (LMICs), where limited laboratory infrastructure constrains phenotypic antimicrobial susceptibility testing. Whole-genome sequencing (WGS)-enabled machine learning (ML) and artificial intelligence (AI) offer rapid approaches for AMR prediction, but their applicability across heterogeneous populations and One Health reservoirs remains uncertain. To map genomic ML/AI approaches for bacterial AMR prediction, focusing on genomic features, model architectures, validation, performance, and LMIC and One Health applicability. A scoping review of 27 studies published between 2020 and 2026 was conducted, including 22 with LMIC-relevant datasets. Evidence was narratively synthesized according to genomic features, modelling strategies, validation approaches, geographic coverage, and ecological context. Studies were categorized using predefined LMIC relevance and One Health criteria. Most studies used WGS-derived features, particularly k-mers and resistance-gene profiles. Tree-based ensembles and regularized regression models predominated, while neural networks were less frequently applied but generally reported high performance. Reported performance ranged from 78%–98% (accuracy or AUC; not directly comparable). External validation using independent LMIC-derived or cross-regional datasets was reported in approximately 30% of studies, whereas cross-country LMIC validation was limited. Six of 22 LMIC-relevant studies (27.3%) incorporated multi-reservoir One Health datasets. Performance varied with dataset composition, genomic feature representation, and model architecture. Explainable AI remained limited. Genomic ML/AI shows strong potential for AMR prediction but remains constrained by limited LMIC representation, external validation, and One Health integration. Expanding geographically diverse WGS datasets, strengthening independent cross-context and cross-country validation, harmonizing evaluation frameworks, and integrating explainable AI are priorities for equitable LMIC deployment.

Discover Public HealthVol. 23(1)
Muhimbili University of Health and Allied Sciences (TZ), Southern African Centre for Infectious Disease Surveillance (TZ), Sokoine University of Agriculture (TZ)
Openalex Percentile: Top 23%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.